about
Virus entry. Lassa virus entry requires a trigger-induced receptor switchConsiderations for the development of Zika virus vaccinesA shared structural solution for neutralizing ebolavirusesStructure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola VirusTaxonomy of the order Mononegavirales: update 2016Calcium Regulation of Hemorrhagic Fever Virus Budding: Mechanistic Implications for Host-Oriented Therapeutic InterventionProduction of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal CattleToll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.A characterization of aerosolized Sudan virus infection in African green monkeys, cynomolgus macaques, and rhesus macaquesRecombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice.Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNAProtection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge.Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteinsSynthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challengeDesigning and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverageCell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection.A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesTaxonomy of the order Mononegavirales: update 2017.Euthanasia assessment in ebola virus infected nonhuman primates.Immune memory to Sudan virus: comparison between two separate disease outbreaks.Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.Filovirus vaccines.Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo.Novel Small Molecule Entry Inhibitors of Ebola Virus.Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane FusionPostexposure antibody prophylaxis protects nonhuman primates from filovirus disease.Generation and characterization of protective antibodies to Marburg virus.Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesMacaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in batsBispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses.Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family FiloviridaeAntibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
P50
Q24299858-263DCBC0-6EA2-4CF4-A80B-A7B74A8ABA23Q24657912-F7E5E915-7030-4B9F-927A-5FF4F44413A6Q27675675-B4C860DB-7A8F-460A-AB47-70CD4F155642Q27676230-3485EF04-D1B0-4006-B006-672F099B289DQ28275807-5A905077-F1DB-435B-9B72-C0ECFA2A9E95Q28550701-81A8F8F5-74E7-4EA0-BA7F-EAFDBD25B8E6Q28603849-366F5892-BC58-4A0A-858E-74F38885D7F7Q31152190-2E6AAAA3-EA4E-45B8-AA20-62EC689C5209Q33404642-FEC3AC75-C76A-4BF7-AC0A-9DFBF0EB01A2Q33439471-BAA175C1-6E30-473B-8181-2E27F7C06646Q33568288-862A9987-41E3-4EFA-B44D-B47A73630ACFQ33768646-F50CA08C-C6CE-4789-A82F-CEB320A3543BQ34029668-13222528-0BBB-424C-BEE8-826BD90DEA18Q34123838-14BAD372-0C74-4D6D-9278-9D34A7A0958CQ34361120-1C7CF8E3-43BA-451F-AB1A-2C5668FB8BCCQ34440836-F3E6C662-04C3-4FDB-951E-72544B5592EEQ34443252-B05E9E62-8436-43FD-BE82-CFB60627CA10Q34500139-543479CE-80F8-460F-870B-904EEF38FCB3Q34539842-68BF23CA-B17B-433A-A23C-5BF678683277Q34554971-6B97D05E-9944-4795-A864-EE91A6FED4AAQ34580900-08DDED3A-244B-4A16-BAA6-4F48C3A89E58Q35014908-159E4F8A-6A8C-43DE-8A90-AADF6C6426A0Q35202880-6223B962-8798-4B50-86F6-68D8AC73939FQ35558539-D848A4E7-1749-4524-AD15-B76541A1E666Q35660156-1819B54B-E374-4631-B0F5-789A86F5B170Q35709878-28219C41-463B-4CC1-A9CF-F53479F95DE6Q35793699-9A4DE189-5C0E-424D-9789-79E7AC75595EQ35809358-F9E79F78-6DDE-46F7-8956-A14C5082D48EQ35882397-0537915A-78AD-456A-8937-1F4C2A42FA28Q36305916-168D8392-2DD8-4000-8DB3-8067640B287EQ36378625-20B154BF-E5F7-4352-8A40-E2D63AF8CEA9Q36433920-4B5BDD10-1223-4C10-9C15-0CB9E9B980E1Q36433965-07608E78-DD69-4CA9-A44F-131EB72BA006Q36452418-13E199E0-6120-4DA8-9A44-2FFA885BD0E5Q36499251-65A4A259-8DAB-422A-9E51-041AF5993981Q36504020-E175F6B6-93CD-4145-81A6-B981DB65BE66Q36759944-4ADA5FB5-3878-40C3-BAB3-8088FC43E9B2Q36845999-4CA0860F-42B7-41FF-960F-06CE441418ACQ36893352-356E1D73-C40D-48AA-AF65-88BB54215B94Q36913606-B453C538-F175-43EB-96DC-BE96E522264E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John M Dye
@ast
John M Dye
@en
John M Dye
@es
John M Dye
@nl
type
label
John M Dye
@ast
John M Dye
@en
John M Dye
@es
John M Dye
@nl
prefLabel
John M Dye
@ast
John M Dye
@en
John M Dye
@es
John M Dye
@nl
P106
P21
P31
P496
0000-0002-0883-5016